Citation

Lemaire-Hurtel AS, Goullé JP, Alvarez JC, Mura P, Verstraete AG. Presse Med. (1983) 2015; 44(10): 1055-1063.

Vernacular Title

Médicaments et conduite automobile.

Affiliation

Hôpital universitaire de Gand, laboratoire de biologie clinique, université de Gand département de biologie clinique, microbiologie et immunologie, 9000 Gand, Belgique.

Copyright

(Copyright © 2015, Elsevier Publishing)

DOI

10.1016/j.lpm.2015.03.007

PMID

25956300

Abstract

Some drugs are known to impair driving because they can change the vision or hearing, and/or disrupt the intellectual or motor abilities: impaired vigilance, sedation, disinhibition effect, the coordination of movement disorders and the balance. The doctor during prescribing and the pharmacist during deliverance of drug treatment should inform their patients of the potential risks of drugs on driving or operating machinery. The driver has direct responsibility, who hired him and him alone, to follow the medical advice received. The pictograms on the outer packaging of medicinal products intended to classify substances according to their risk driving: The driver can whether to observe simple precautions (level one "be prudent"), or follow the advice of a health professional (level two "be very careful"), or if it is totally not drive (level three "danger caution: do not drive"). This classification only evaluates the intrinsic danger of drugs but not the individual variability. Medicines should be taken into account also the conditions for which the medication is prescribed. It is important to inform the patient on several points.

Language: fr